Conférences  >  Chimie  >  Biochimie et chimie médicale, toxicologie  >  Royaume-Uni

Royal Society of Chemistry (RSC)

The RSC Chemical Biology and Bio-organic Group invite you to their annual postgraduate meeting which will take place in-person at the University of Oxford. This meeting is designed to to give early career researchers, from across a broad range of chemical biology backgrounds, a platform to share their latest research.

Royal Society of Chemistry (RSC)

With more than 70 FDA-approved small molecules, the field of kinase inhibition continues to attract significant investment from the drug discovery and development community. The 10th SCI/RSC symposium on kinases will encompass plenary lectures on emergent topics and case studies of ongoing programmes as well as successful past programmes. A range of topics including new screening approaches, brain penetrant kinase inhibitors, induced protein degradation, allosteric inhibitors and kinase inhibition for immuno-oncology will be covered, along with views and perspectives on the future of kinase inhibitor research.

Royal Society of Chemistry

A one day event of discussion and case studies to bring together practicing lawyers and legal academics, with toxicologists and scientists, to increase understanding between the two and to understand each other's strengths and limitations.

Royal Society of Chemistry (RSC)

This meeting, organised by the RSC Environmental Chemistry Group, SETAC UK, and BMSS Environmental and Food Analysis SIG will comprise presentations and posters.

Environmental processes in soil, water and air, Emerging contaminants and novel techniques, Food and environment nexus, Atmospheric chemistry, Ecotoxicology

Chimie de l'environnement, géochimie,    Chimie alimentaire et agronomie

Scientific Update Ltd.

Medicinal chemists need to understand the relationship between chemical structure and the physical properties of molecules and how this translates into compound stability and the interaction of the molecule with biological structures. These biological targets include proteins, lipids, nucleic acids and cell membranes. Interaction of the molecules with these targets affects the distribution of the compound in biological systems and modulates biological function. To do this successfully the medicinal chemist needs to be aware of how target selection is carried out and how this effects lead generation. The medicinal chemist needs knowledge of structure property relationships, the physico-chemical properties of drugs and how these molecules interact with the body– pharmacokinetics and ADME (Absorption, Distribution, Metabolism and Excretion).